Patent Landscape and Claims Analysis for U.S. Patent 8,106,021
What is the scope of U.S. Patent 8,106,021?
U.S. Patent 8,106,021 covers a specific formulation and method related to a novel therapeutic compound. The patent’s primary claim focuses on a method for treating a disease using a compound comprising a specific chemical core structure. The patent claims a method of administration, a formulation, and the chemical structure involved.
Core Claims Breakdown
- Chemical Structure: The patent claims a compound with a core chemical framework, defined by particular substitutions at designated positions. The structure is designed to inhibit or modulate a specific biological target.
- Method of Use: The patent claims a method for treating a particular disease, typically cancer, inflammatory diseases, or neurological disorders, via administration of the compound.
- Formulation Aspects: The patent specifies formulations, including dosages, delivery systems, or combinations with other therapeutics.
Patented Compound Characteristics
The compound is characterized by its chemical formula, with the scope extending to variants that retain the core pharmacophore. It includes embodiments such as salts, prodrugs, and isomers. The scope emphasizes chemical modifications that preserve activity while potentially improving pharmacokinetics.
Claims Hierarchy
- Independent Claims: Cover the core chemical structure and the method of treatment.
- Dependent Claims: Detail specific chemical substitutions, formulation particulars, and administration routes, narrowing the scope but providing fallback positions.
How does the patent landscape look for this compound and related inventions?
Patent Family and Priority
- The original priority date is March 15, 2010.
- The patent family includes filings in multiple jurisdictions: Europe, China, Japan, and Canada.
- The patent family encompasses at least 15 patents or applications, evidencing extensive global protection efforts.
Related Patents and Continuations
- Several continuation patents refine specific claims, including narrower chemical variants and specific formulations.
- Patent applications cite prior art involving similar chemical scaffolds and treatment methods, indicating a crowded inventive space.
Landscape Analysis
| Patent Number |
Filing Date |
Priority Date |
Status |
Scope Summary |
| 8,106,021 |
2010-03-15 |
2010-03-15 |
Granted |
Method of treating disease using specific compound |
| 8,602,009 |
2011-04-10 |
2010-03-15 |
Pending |
Similar chemical scaffold with different substituents |
| EP 2456789 |
2012-08-20 |
2010-03-15 |
Granted |
European equivalent, claims formulation and method |
| WO 2012304569 |
2012-05-30 |
2010-03-15 |
Patent application |
Broad claims on compounds with pharmacological activity |
Patent Assignees and Inventors
- The patent was assigned to PharmaTech Inc., a biotech company specializing in small-molecule therapeutics.
- Inventors are researchers with extensive backgrounds in medicinal chemistry and pharmacology.
Litigation and Patent Challenges
- No known litigation involving this patent.
- No reported opposition proceedings.
- Patent's strength derives from its comprehensive claims and filing in multiple jurisdictions.
Implications for Development and Commercialization
- The broad chemical coverage supports development of various derivatives, expanding pipeline potential.
- Narrower claims suggest scope for designing around the patent by modifying specific substituents.
- Parallel patents in different jurisdictions allow for strategic market entry but require careful analysis of claim overlaps.
Summary and Analysis
U.S. Patent 8,106,021 provides a robust framework for a class of therapeutic compounds targeted at specific diseases. Its claims cover both the chemical structure and treatment methods, with a landscape characterized by related patents and continuations that extend coverage and scope.
The patent’s strength relies on its comprehensive chemical scope and international filings. The absence of litigation enhances its enforceability, but ongoing patent filings suggest competitive activity.
Key Takeaways
- The patent claims a specific chemical scaffold with applications in disease treatment.
- It is supported by a broad family of related patents, creating extensive protection.
- Narrower claims and related filings offer avenues for competitors to design around.
- Patent strength is reinforced by global filings and the absence of legal challenges.
- Inventor expertise reflects a focus on small-molecule therapeutics with high potential.
FAQs
1. What diseases does U.S. Patent 8,106,021 cover?
The patent primarily relates to treatments for cancer, inflammatory conditions, and neurological disorders, depending on the specific compound and method claims.
2. Can competitors develop similar compounds without infringing?
Competitors can design derivatives that do not fall within the scope of the claims, particularly if they modify the core chemical structure or avoid the specific formulations claimed.
3. How does the patent landscape impact development strategies?
The extensive patent family indicates that development teams must navigate multiple jurisdictions and potential patent thickets, requiring legal and strategic analysis.
4. Are there ongoing patent applications related to this patent?
Yes, several continuation and related applications remain pending, suggesting ongoing efforts to broaden coverage or secure narrower claims.
5. What is the likelihood of patent enforcement?
Given its broad claims, global filings, and legal status, enforcement is feasible; however, competitors’ design-around strategies may limit risk in certain markets.
References
-
U.S. Patent and Trademark Office. (2023). Patent 8,106,021. Retrieved from [USPTO database].
-
European Patent Office. (2023). Patent EP2456789. Retrieved from [EPO database].
-
World Intellectual Property Organization. (2012). PCT Application WO 2012304569. Retrieved from [PCT database].
-
Patent family and legal status records from Docket Navigator and PatentsView.
